» Articles » PMID: 1848877

Retinoic Acid Receptor Gene Expression in Human Skin

Overview
Publisher Elsevier
Specialty Dermatology
Date 1991 Apr 1
PMID 1848877
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Human skin exhibits a characteristic, pleiotypic response to topical retinoic acid. In attempting to understand this response at the molecular level, we have used fast protein liquid chromatography (FPLC) and RNA blot hybridization to characterize the expression of the nuclear retinoic acid receptor (RAR) alpha, beta, and gamma genes in adult human epidermis. Size exclusion FPLC of 0.6 M NaCl nuclear extracts prepared from keratome biopsies revealed two peaks of specific [3H] retinoic acid (RA) binding at Mr 45 and 18 kDa, in agreement with the expected sizes of RAR and cellular RA binding protein. Blot hybridization analysis of total RNA extracted from keratome biopsies revealed that RAR-gamma was the predominant RAR species expressed in human epidermis, as RAR-alpha transcripts were detectable only at low levels and RAR-beta transcripts were undetectable. RAR transcripts were not induced by topical treatment with 0.1% RA cream under occlusion for 4 h or 4 d. Moreover, there was no significant difference in RAR-gamma transcript levels in normal and psoriatic epidermis. RAR-gamma transcripts were constitutively expressed not only in cultured human keratinocytes, but also in human dermal and lung fibroblasts. RAR-beta was induced by RA in dermal fibroblasts, but not in keratinocytes. RA induced IL-1 beta transcripts in keratinocytes rapidly (2 to 4 h) and at low concentrations (3 x 10(-10) M), consistent with activation of the IL-1 beta gene via RAR. These results demonstrate constitutive expression of RAR-gamma in human epidermis, and suggest that RAR-gamma is a molecular target of RA action in adult human skin.

Citing Articles

The Relevance and Potential Role of Orbital Fat in Inflammatory Orbital Diseases: Implications for Diagnosis and Treatment.

Dadson P, Ngum P, Juarez-Orozco L, Ntodie M, Loba P Ophthalmol Ther. 2024; 14(2):247-281.

PMID: 39680323 PMC: 11754589. DOI: 10.1007/s40123-024-01079-7.


Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis.

Dolivo D, Rodrigues A, Galiano R, Mustoe T, Hong S J Invest Dermatol. 2023; 143(9):1724-1734.e15.

PMID: 36804965 PMC: 10432574. DOI: 10.1016/j.jid.2023.01.024.


Effect of regioisomers of hydroxystearic acids as peroxisomal proliferator-activated receptor agonists to boost the anti-ageing potential of retinoids.

Rawlings A, Wandeler E, Bendik I, Fuchs P, Monneuse J, Imfeld D Int J Cosmet Sci. 2021; 43(5):619-626.

PMID: 34403541 PMC: 9255590. DOI: 10.1111/ics.12730.


Resistin, a Novel Host Defense Peptide of Innate Immunity.

Li Y, Yang Q, Cai D, Guo H, Fang J, Cui H Front Immunol. 2021; 12:699807.

PMID: 34220862 PMC: 8253364. DOI: 10.3389/fimmu.2021.699807.


50 Years of Topical Retinoids for Acne: Evolution of Treatment.

Baldwin H, Webster G, Gold L, Callender V, Cook-Bolden F, Guenin E Am J Clin Dermatol. 2021; 22(3):315-327.

PMID: 33871811 DOI: 10.1007/s40257-021-00594-8.